Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949464 · ClinicalTrials.gov registry record · NA
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
A NA study of HIV Infection and Tobacco-Related Carcinoma, sponsored by AIDS Malignancy Consortium.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 11
- Study locations
NCT04949464: Recruiting NA study of HIV Infection and Tobacco-Related Carcinoma, sponsored by AIDS Malignancy Consortium.
NCT04949464 is a NA study of HIV Infection and Tobacco-Related Carcinoma that is actively recruiting participants, run by AIDS Malignancy Consortium. The registered enrollment target is 100 participants, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (59% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04949464, a NA study of HIV Infection and Tobacco-Related Carcinoma, is actively recruiting participants, sponsored by AIDS Malignancy Consortium.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 11
- Study locations
Study Summary
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Primary Outcome
Adherence is defined by meeting at least one of the following: logging into the application at least 10 of 42 days; watching of \>= 4 of 8 video sessions; AND meeting the definition of Engagement with the intervention as defined by at least one of the following: use of the "HELP" button at least once; OR responding to the text messaging "check-in" at least once. Will be summarized as the proportion of participants who meet the criteria as defined above among all the participants who are enrolled
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- BEHAVIORAL Smoking Cessation Intervention
Study Locations (11)
New York
- Weill Cornell Medicine - Cornell Clinical Trials Unit - New York
- Mount Sinai Hospital - New York
- Montefiore Medical Center - The Bronx
California
- UC San Diego Moores Cancer Center - La Jolla
District of Columbia
- George Washington University - Washington D.C.
Florida
- Moffitt Cancer Center - Tampa
Missouri
- Washington University School of Medicine - St Louis
Ohio
- The Ohio State University James Cancer Hospital - Columbus
Pennsylvania
- Thomas Jefferson University - Philadelphia
Texas
- University of Texas M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-22 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT04949464 shows while recruiting
NCT04949464 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with HIV Infection appearing as the primary indexed condition, and to 2 interventions - of which Computed Tomography is the first listed.
NCT04949464 lists 11 locations in 9 states (New York, California, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT04949464 about?
NCT04949464 is a clinical study titled "Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study". This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
What is the current status of trial NCT04949464?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-03-22. Estimated completion is 2027-03-31.
What conditions does trial NCT04949464 study?
This clinical trial studies the following conditions: HIV Infection, Tobacco-Related Carcinoma.
What interventions are being tested in trial NCT04949464?
The interventions under investigation include: Computed Tomography (PROCEDURE), Smoking Cessation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04949464?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04949464 being conducted?
This trial has 11 study locations across California, District of Columbia, Florida, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04949464's enrollment target sits among peer trials
100 26th of 73 higher than 48 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
RECRUITING · NA
-
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI